CClinicalTrials.gg
Status unknownNCT02061176Updated Dec 4, 2017

THD Versus Open Haemorrhoidectomy

An interventional study of Transanal Haemorrhoidal Dearterialization and Open Haemorrhoidectomy in Hemorrhoids, sponsored by Holbaek Sygehus. Status unknown at 1 site in Denmark. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2017-12-04.

Sponsored by Holbaek Sygehus · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2017), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Oct 2013, registered Feb 2014).
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

A randomised study comparing Transanal Haemorrhoidal Dearterialization (THD) and Open Haemorrhoidectomy (OH) for the treatment of prolapsing haemorrhoids. The primary aim of the study is to evaluate the long-term effect on haemorrhoidal symptoms one year postoperatively.

Secondary endpoints are postoperative pain, complications, effect on anal continence, recovery and return to normal activity, quality of life and health cost analysis.

02

Conditions studied

  • Hemorrhoids

Browse trials for

Keywords

  • Hemorrhoids
  • Haemorrhoids
  • Transanal Haemorrhoidal Dearterialization
  • Transanal Hemorrhoidal Dearterialisation
  • Open Haemorrhoidectomy
  • Open Hemorrhoidectomy
03

In context

Hemorrhoids

221 studies on the registry are indexed under Hemorrhoids; 64 are open to participants now.

This study's planned enrollment of 90 is close to the median of 97 across 169 interventional studies indexed under Hemorrhoids.

Browse Hemorrhoids studies →

Lead sponsor

Holbaek Sygehus is the lead sponsor of 26 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • The patient has Grade III-IV haemorrhoids or Grade II haemorrhoids with bleeding resistant to rubber band ligation or sclerotherapy
  • The patient has a Haemorrhoidal Symptom Score of 4 or more
  • The patient has an American Society of Anaesthesiologists (ASA) score I-II
  • The patient's age is 18-85 years at inclusion
  • The patient has had a colonoscopy, sigmoidoscopy or rigid rectoscopy within 3 months before inclusion

Exclusion criteria

Exclusion Criteria:

  • The patient has had previous operation for haemorrhoids within the last 2 years
  • The patient has had previous operation for anal incontinence
  • The patient has an active anal fistula
  • The patient has an active anal fissure
  • The patient has anal incontinence for solid stools
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Transanal Haemorrhoidal Dearterialization

    Patients randomised to Transanal Haemorrhoidal Dearterialization.

    Procedure: Transanal Haemorrhoidal Dearterialization

  • Active comparator
    Open Haemorrhoidectomy

    Patients randomised to Open Haemorrhoidectomy

    Procedure: Open Haemorrhoidectomy

Interventions

  • ProcedureTransanal Haemorrhoidal Dearterialization

    Also known as: Hemorrhoidal Artery Ligation

  • ProcedureOpen Haemorrhoidectomy

    Also known as: Milligan Morgan, Haemorrhoidectomy

06

What researchers measure

Primary outcomes

  1. Haemorrhoidal Symptoms

    Five questions regarding haemorrhoidal symptoms (pain, bleeding, itching, soiling and prolapse) are used to grade the symptom load. Each symptom is graded from 0-4, giving a total score from 0-20. The symptom score is registered preoperatively, 3 and 12 months and 5 years postoperatively.

    Time frame: 1-year and 5-years postoperatively

Secondary outcomes

  1. Postoperative pain

    Postoperative pain is registered using visual analog scale (VAS), by the hospital staff in the immediate postoperative course during hospital stay and by the patient the first 14 days postoperatively.

    Time frame: 14 days postoperatively

  2. Complications

    Early and late complications are registered at 3 and 12 months and 5 years follow up.

    Time frame: 1-year and 5-years postoperatively

  3. Anal continence

    Effect on anal continence is evaluated by Wexner Anal Incontinence Score and Revised Faecal Incotinence Score (RFIS) preoperatively, 3- and 12 months and 5 years postoperatively.

    Time frame: 1-year and 5-years postoperatively

  4. Quality of Life

    QoL is evaluated using Short Health Scale, Short Form(SF)-36 and EQ-5D preoperatively, 1-year and 5-years postoperatively.

    Time frame: 1-year and 5-years postoperatively

  5. Health cost analysis

    Health cost analysis will be based on an estimate of the cost of the operations, recovery of the patients and effect (need for further procedures or medical care).

    Time frame: 1-year and 5-years postoperatively

07

Study locations

1 site
  • Departement of Surgery, Holbaek County Hospital.
    Holbaek, 4300, Denmark
08

References and documents

Publications

  • Rorvik HD, Campos AH, Styr K, Ilum L, McKinstry GK, Brandstrup B, Olaison G. Minimal Open Hemorrhoidectomy Versus Transanal Hemorrhoidal Dearterialization: The Effect on Symptoms: An Open-Label Randomized Controlled Trial. Dis Colon Rectum. 2020 May;63(5):655-667. doi: 10.1097/DCR.0000000000001588. PubMed 31996581 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 4, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02061176
Lead sponsor
Holbaek Sygehus
Responsible party
Per Olov Gunnar Olaison (MD, PhD, Holbaek Sygehus) — Principal investigator
First posted
Feb 12, 2014
Start date
Oct 2013
Primary completion
Dec 2021 (estimated)
Completion
Dec 2021 (estimated)
Last update
Dec 4, 2017

Study contacts

Gunnar Olaison, MD, Ph.D
principal investigator · Departement of Surgery, Holbaek County Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion